Zhang, L.X., Zhang, B., Liu, X.Y., Wang, Z.M., Qi, P., Zhang, T.Y., et al. (2022) Advances in the Treatment of Secondary and Tertiary Hyperparathyroidism. Frontiers in Endocrinology, 13, Article 1059828.
https://doi.org/10.3389/fendo.2022.1059828

has been cited by the following article:

• TITLE: Secondary Hyperparathyroidism in Dialysis Patients: Short- and Long-Term Outcomes of Conservative Parathyroidectomy

  AUTHORS: Imane Saidi, Sara Elmaakoul, Naima Ouzeddoun, Loubna Benamar

  KEYWORDS: Secondary Hyperparathyroidism, Dialysis, Chronic Kidney Disease, Conservative Subtotal Parathyroidectomy

  JOURNAL NAME: Open Journal of Nephrology, Vol.14 No.2, April 23, 2024

  ABSTRACT: Secondary hyperparathyroidism (HPT) is frequent in dialysis patients. Parathyroidectomy (PTX) is indicated for patients who failed medical therapy. We reviewed the data from 184 dialysis patients who underwent PTX between January 2015 and January 2023. We aimed to evaluate the short and long term outcomes of PTX in dialysis patients, comparing the conservative 3/4 versus 7/8 techniques in this population.166 dialysis patients with secondary HPT were included. A conservative subtotal PTX (sPTX) 7/8 was performed in 72% of patients and sPTX 3/4 in 28% of them. Severe postoperative hypocalcaemiaocurred in 45 patients (27%). Hypocalcaemia was significantly more frequent in the sPTX 7/8 group (p = 0.012). One case of persistent HPT (0.6%) and 20 cases of recurrence (12%) were diagnosed. Recurrence was more frequent in the sPTX 3/4 group (15%). No deaths were reported during the perioperative period.